ADVOCATE APIXABAN DOSING TO AVOID THE OCCURRENCE OF CANCER ASSOCIATED THROMBOEMBOLIC EVENTS Trademark

Trademark Overview

On Thursday, April 14, 2011, a trademark application was filed for ADVOCATE APIXABAN DOSING TO AVOID THE OCCURRENCE OF CANCER ASSOCIATED THROMBOEMBOLIC EVENTS with the United States Patent and Trademark Office. The USPTO has given the ADVOCATE APIXABAN DOSING TO AVOID THE OCCURRENCE OF CANCER ASSOCIATED THROMBOEMBOLIC EVENTS trademark a serial number of 85294809. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 29, 2014. This trademark is owned by Bristol-Myers Squibb Company. The ADVOCATE APIXABAN DOSING TO AVOID THE OCCURRENCE OF CANCER ASSOCIATED THROMBOEMBOLIC EVENTS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use
advocate apixaban dosing to avoid the occurrence of cancer associated thromboembolic events

General Information

Serial Number85294809
Word MarkADVOCATE APIXABAN DOSING TO AVOID THE OCCURRENCE OF CANCER ASSOCIATED THROMBOEMBOLIC EVENTS
Filing DateThursday, April 14, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 29, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2011

Trademark Statements

Disclaimer with Predetermined Text"APIXABAN DOSING TO AVOID THE OCCURRENCE OF CANCER ASSOCIATED THROMBOEMBOLIC EVENTS"
Goods and ServicesMedical and scientific research, namely, conducting clinical trials relating to pharmaceutical preparations for human use

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 18, 2011
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10154
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Monday, December 29, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 29, 2014ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 20, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 19, 2014EXTENSION 5 GRANTED
Friday, May 16, 2014EXTENSION 5 FILED
Friday, May 16, 2014TEAS EXTENSION RECEIVED
Tuesday, November 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2013EXTENSION 4 GRANTED
Wednesday, November 13, 2013EXTENSION 4 FILED
Wednesday, November 13, 2013TEAS EXTENSION RECEIVED
Tuesday, May 21, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 20, 2013EXTENSION 3 GRANTED
Friday, May 17, 2013EXTENSION 3 FILED
Friday, May 17, 2013TEAS EXTENSION RECEIVED
Tuesday, March 12, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Tuesday, November 13, 2012EXTENSION 2 GRANTED
Friday, November 9, 2012EXTENSION 2 FILED
Friday, November 9, 2012TEAS EXTENSION RECEIVED
Friday, May 11, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
Thursday, May 10, 2012EXTENSION 1 GRANTED
Tuesday, April 17, 2012EXTENSION 1 FILED
Thursday, May 10, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 17, 2012TEAS EXTENSION RECEIVED
Tuesday, November 22, 2011NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 27, 2011PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2011NOTICE OF PUBLICATION
Thursday, August 25, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 24, 2011ASSIGNED TO LIE
Wednesday, August 10, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 25, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 25, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 25, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 18, 2011EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED
Monday, July 18, 2011EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Wednesday, June 29, 2011ASSIGNED TO EXAMINER
Thursday, April 28, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 28, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 25, 2011TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Monday, April 25, 2011TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, April 18, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 18, 2011NEW APPLICATION ENTERED IN TRAM

Related Keywords

associated thromboembolic events cancer occurrence apixaban dosing avoid advocate relating pharmaceutical preparations human trials clinical scientific research namely conducting